• No results found

Care for consequences in children treated for leukemia or brain tumor - Title pages

N/A
N/A
Protected

Academic year: 2021

Share "Care for consequences in children treated for leukemia or brain tumor - Title pages"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE (Digital Academic Repository)

Care for consequences in children treated for leukemia or brain tumor

Aukema, E.J.

Publication date

2013

Link to publication

Citation for published version (APA):

Aukema, E. J. (2013). Care for consequences in children treated for leukemia or brain tumor.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

(2)

Care for consequences

in children treated for leukemia or brain tumor

(3)

© Eline J. Aukema

ISBN: 978-90-820062-1-6

The study presented in this thesis was fi nancially supported by:

KIKA, Johanna Kinderfonds, Gratama foundation, Research school of

Neuroscience and SKK.

The printing of this thesis was fi nancially supported by:

Academic Medical Center (AMC), Psychosocial department Emma

Children’s Hospital, GlaxoSmithKline, Kennedy van der Laan (www.

rechtindezorg.nl) and Tom Voûte Fonds.

Design by:

(4)

Care for consequences

in children treated for leukemia or brain tumor

ACADEMISCH PROEFSCHRIFT

ter verkrijging van de graad van doctor aan de Universiteit van Amsterdam op gezag van de Rector Magnificus prof.dr. D.C. van den Boom ten overstaan van een door het college voor promoties ingestelde commissie,

in het openbaar te verdedigen in de Aula der Universiteit op woensdag 17 april 2013, te 11:00 uur

door

Eline Johanna Aukema geboren te Nijmegen

(5)

Promotiecommissie

Promotores:

prof. dr. M.A. Grootenhuis

prof. dr. B.F. Last

Co-promotores:

dr. A.Y.N. Schouten-van Meeteren

prof. dr. H.N. Caron

Overige leden:

prof. dr. H.S.A. Heymans

prof. dr. F. Nollet

prof. dr. G.J.L Kaspers

dr. S. B. Schagen

dr. J. Huisman

dr. K.J. Oostrom

Faculteit der geneeskunde

Referenties

GERELATEERDE DOCUMENTEN

Topographic maps for LI (left) and HI (right), at Pz, for No-Go trials in the Go/No-Go task. Visual representation of one trial in the SSRT. a blue circle) on Go trials (75%

Stopping the “World’s Greatest Threat”: Canadian Policy and Rhetoric towards the Iranian Nuclear Program during Stephen Harper’s Conservative Government, 2006-2015.. by

I think joy, and like, you know, just taking care of yourself and the people around you is really important to this work because we’re in it for the long haul. we have to take care

German’s report, the Corporate Registration program plays a key role in GPEB’s regulatory framework, and is a principal mechanism through which GPEB maintains control over

Britton (1997) concluded that race and gender are contributing factors in stress and further identified the need for future researchers to explore how these intersections

These structural investigations into the mechanism for germ-line antibody recognition of carbohydrate antigens utilizing chlamydial-specific and anti-lipid A antibodies

Our structural analysis revealed that while the N- terminal region of TbFam50.360 adopted a three-helical structure similar to previously characterized trypanosome surface

I showed that data on the structural differences between the native and aggregated forms of the prion protein, obtained from multiple structural proteomics approaches